psychiatric disorders

Global head speaks on role of insurance in mental health progress

This is the third article of a four-part series that will also include an overview and articles further exploring the survey’s implications for product development and claims.

More than ever, understanding and managing suicide and mental health risks are important for the life and health insurance industry. How can insurers address and proactively manage this issue? Is there any part of the existing insurance application process, such as the life insurance underwriting process, that can be improved to assess insured populations’ mental health and suicide risks more effectively?

During the past 30 years, autism spectrum disorder (ASD) has emerged as one of the faster-growing diagnosed disorders of childhood. Its growth in prevalence among children has led to the need for a much greater focus on this area from not only a clinical lens but also an insurance one.
 

This report examines the impact of mental illness on U.S. population mortality and longevity. It also explores the impact of the COVID-19 pandemic on mental illness.
 

Much of the available data regarding the therapeutic use of psychedelics for mental health disorders remains introductory; however, momentum is building with the potential to offer unique treatments for many complex mental health disorders.

Excessive users of the internet and mobile phones are at high risk of non-substance use disorder and subsequent mental health issues. In this research article, RGA's Hilary Henly, Global Medical Researcher, provides an overview of the issue.
 

The new American Psychiatric Association’s (APA) “Diagnostic and Statistical Manual (DSM) of Mental Disorders”, Fifth Edition, Text Revision (DSM‑5‑TR) was released in March. It’s been nine years since the publication DSM 5, so an update was overdue.
 

Will the COVID-19 pandemic cause ‘diseases of despair’ to rise and will this affect long term trends in mortality and morbidity?
 

When it comes to risk selection, insurers typically assess whether an applicant has a clinically diagnosed mental illness like schizophrenia or bi-polar disorder.